Foster City, CA, United States of America

Xiaojing Wang

This inventor holds 34 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 17 EPO patents, primarily in Estrogen Receptor Modulators. Top assignees: Genentech, Inc., Gilead Connecticut, Inc., F. Hoffmann-La Roche Ag. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaojing Wang. Retrieved from https://idiyas.com/inventor/xiaojing-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 34 (Patent Applications = 10)

% Patents Active = 64.7

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 200(Granted Patents)

Company Filing History:

Gilead Connecticut, Inc.

patents

5 out of 181

F. Hoffmann-La Roche Ag

patents

4. 5 out of 1,035

Isis Pharmaceuticals, Inc.

Cgi Pharmaceuticals, Inc.

patents

7. 1 out of 37

Inotek Pharmaceuticals Corporation

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Estrogen Receptor Modulators

Tetrahydropyrido Compounds

Heterocyclic Compounds

Pyridone Derivatives

Antibacterial Agents

Aza-Pyridone Compounds

Pyrazol-4-Yl Compounds

Cyclic Ether Compounds

Pyrazolo Compounds

Indenoisoquinolinone Analogues

Lactams

Aminoglycoside Analogs

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233052 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2025-02-25),

2. 12187709 - Lactams as CBL-B inhibitors selective over C-CBL (2025-01-07),

3. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2021-04-06),

4. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof (2020-05-19),

5. 10399939 - Tetrahydronaphthalene estrogen receptor modulators and uses thereof (2019-09-03),

6. 10344040 - Pyridone and aza-pyridone compounds and methods of use (2019-07-09),

7. 10053469 - Pyridone and aza-pyridone compounds and methods of use (2018-08-21),

8. 10053451 - Heterocyclic estrogen receptor modulators and uses thereof (2018-08-21),

9. 9980947 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2018-05-29),

10. 9969732 - Tetrahydroisoquinoline estrogen receptor modulators and uses thereof (2018-05-15),

11. 9963446 - Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2018-05-08),

12. 9931323 - Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2018-04-03),

13. 9850239 - Pyrazolo[3,4-c]pyridine compounds and methods of use (2017-12-26),

14. 9845291 - Estrogen receptor modulators and uses thereof (2017-12-19),

15. 9573943 - Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use (2017-02-21),

Title: Xiaojing Wang - Innovator from Foster City, CA

Introduction: Xiaojing Wang is a pioneering inventor based in Foster City, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiaojing Wang holds several patents in the areas of artificial intelligence, machine learning, and data analytics, showcasing her expertise in cutting-edge technologies.

Career Highlights: With a background in computer science and engineering, Xiaojing Wang has had a successful career working for leading tech companies, where she has spearheaded projects that have revolutionized the industry.

Collaborations: Throughout her career, Xiaojing Wang has collaborated with top researchers, engineers, and developers to bring innovative ideas to life, fostering a culture of creativity and excellence in the teams she works with.

Conclusion: Xiaojing Wang's passion for innovation and her relentless drive to push the boundaries of technology make her a standout figure in the world of inventors, inspiring the next generation of innovators to dream big and create the future.

Profile summary based on public USPTO records.